• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于临床、超声参数及肿瘤标志物的数学模型和评分系统在附件肿瘤术前诊断中的应用

Clinical, ultrasound parameters and tumor marker-based mathematical models and scoring systems in pre-surgical diagnosis of adnexal tumors.

作者信息

Abdalla Nabil, Winiarek Joanna, Bachanek Michał, Cendrowski Krzysztof, Sawicki Włodzimierz

机构信息

Medical University of Warsaw.

出版信息

Ginekol Pol. 2016;87(12):824-829. doi: 10.5603/GP.2016.0096.

DOI:10.5603/GP.2016.0096
PMID:28098934
Abstract

The choice of management for patients with adnexal tumors requires careful pre-surgical assessment. In case of adnexal masses, the diagnostic difficulties arise from the heterogenic nature of the adnexal diseases, presence of multiple functional changes, and lack of early symptoms of malignancy. A reliable pre-surgical differentiation cannot be performed using clinical features, ultrasound examination, or tumor markers alone. New diagnostic techniques and novel markers are under investigations, however no single test can be used to conclusively differentiate between malignant and non-malignant adnexal masses. Mathematical models and scoring systems based on different clinical, ultrasonographic and laboratory parameters alone or together may facilitate the diagnosis. Selected mathematical models and scoring systems are presented in this article. Models using only ultrasound features include simple rules, regression models, Gynecologic Imaging Report and Data System, and various morphologic scores. Some logistic regression models are based on multiple clinical and ultrasound data. The OVA1 test is based on five tumor markers without using other data. The Risk of Malignancy Algorithm uses two tumor markers with one clinical parameter. i.e. the menopausal status. Some models used clinical, ultrasound and tumor marker data together. This group of models includes risk of malignancy indices, artificial neural networks, and the ADNEX model. Although some of these models have been compared in the literature, more prospective studies are needed to select the most effective model, to develop the existing models, or to create new more effective models of oncological assessment of the adnexal tumors.

摘要

附件肿瘤患者的治疗方案选择需要进行仔细的术前评估。对于附件包块,诊断困难源于附件疾病的异质性、多种功能变化的存在以及恶性肿瘤早期症状的缺乏。仅依靠临床特征、超声检查或肿瘤标志物无法进行可靠的术前鉴别。新的诊断技术和新型标志物正在研究中,然而没有单一的检测方法可用于明确区分恶性和非恶性附件包块。基于不同临床、超声和实验室参数单独或联合使用的数学模型和评分系统可能有助于诊断。本文介绍了一些选定的数学模型和评分系统。仅使用超声特征的模型包括简单规则、回归模型、妇科影像报告和数据系统以及各种形态学评分。一些逻辑回归模型基于多种临床和超声数据。OVA1检测基于五种肿瘤标志物,不使用其他数据。恶性风险算法使用两种肿瘤标志物和一个临床参数,即绝经状态。一些模型同时使用临床、超声和肿瘤标志物数据。这组模型包括恶性风险指数、人工神经网络和ADNEX模型。尽管这些模型中的一些已在文献中进行了比较,但仍需要更多的前瞻性研究来选择最有效的模型、改进现有模型或创建更有效的附件肿瘤肿瘤学评估新模型。

相似文献

1
Clinical, ultrasound parameters and tumor marker-based mathematical models and scoring systems in pre-surgical diagnosis of adnexal tumors.基于临床、超声参数及肿瘤标志物的数学模型和评分系统在附件肿瘤术前诊断中的应用
Ginekol Pol. 2016;87(12):824-829. doi: 10.5603/GP.2016.0096.
2
[Difficulties in differential diagnosis of adnexal masses during pregnancy: the role of greyscale and color doppler sonography].[孕期附件包块的鉴别诊断难点:灰阶及彩色多普勒超声检查的作用]
Ginekol Pol. 2001 Dec;72(12A):1281-6.
3
Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.附件包块恶性风险评估:ADNEX模型的外部验证及与其他常用超声方法的比较
Ultrasound Obstet Gynecol. 2017 Jun;49(6):784-792. doi: 10.1002/uog.17225.
4
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group.基于国际卵巢肿瘤分析小组的简单规则预测附件包块的恶性风险。
Am J Obstet Gynecol. 2016 Apr;214(4):424-437. doi: 10.1016/j.ajog.2016.01.007. Epub 2016 Jan 19.
5
Artificial neural network models for the preoperative discrimination between malignant and benign adnexal masses.用于术前鉴别附件肿块良恶性的人工神经网络模型
Ultrasound Obstet Gynecol. 1999 Jan;13(1):17-25. doi: 10.1046/j.1469-0705.1999.13010017.x.
6
Inclusion of CA-125 does not improve mathematical models developed to distinguish between benign and malignant adnexal tumors.纳入CA - 125并不能改善为区分良性和恶性附件肿瘤而建立的数学模型。
J Clin Oncol. 2007 Sep 20;25(27):4194-200. doi: 10.1200/JCO.2006.09.5943. Epub 2007 Aug 13.
7
Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses.超声主观评估优于肿瘤恶性风险指数(RMI)或卵巢恶性肿瘤算法(ROMA),可用于鉴别附件良恶性肿块。
Eur J Cancer. 2012 Jul;48(11):1649-56. doi: 10.1016/j.ejca.2011.12.003. Epub 2012 Jan 5.
8
Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help.附件肿块使用灰阶和多普勒超声检查结果的主观评估难以明确良恶性:逻辑回归模型无助于诊断。
Ultrasound Obstet Gynecol. 2011 Oct;38(4):456-65. doi: 10.1002/uog.9030. Epub 2011 Sep 13.
9
An improved risk of malignancy index in diagnosis of adnexal mass.改良的卵巢肿物恶性风险指数在卵巢肿物诊断中的应用。
Chin Med J (Engl). 2012 Feb;125(3):533-5.
10
Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.IOTA ADNEX 模型在中国妇科肿瘤中心评估附件肿块的性能。
Ultrasound Obstet Gynecol. 2019 Dec;54(6):815-822. doi: 10.1002/uog.20363. Epub 2019 Nov 11.

引用本文的文献

1
Primary ovarian leiomyoma with calcification: A case report.原发性卵巢平滑肌瘤伴钙化:一例报告。
Medicine (Baltimore). 2024 Jul 26;103(30):e39122. doi: 10.1097/MD.0000000000039122.
2
Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy.评估人附睾蛋白4(HE4)在卵巢癌诊断中的应用:首次复发和二次复发情况,以及二线和三线化疗期间HE4浓度分析
Diagnostics (Basel). 2023 Jan 26;13(3):452. doi: 10.3390/diagnostics13030452.
3
Detection of Epithelial Ovarian Cancer using C8Magnetic Bead Separation and MALDI-TOF Plasma Proteome Profiling in Egyptian Females.
在埃及女性中使用C8磁珠分离和基质辅助激光解吸电离飞行时间质谱血浆蛋白质组分析检测上皮性卵巢癌
Asian Pac J Cancer Prev. 2019 Dec 1;20(12):3603-3609. doi: 10.31557/APJCP.2019.20.12.3603.
4
RAS Mutation in Mucinous Carcinoma of the Ovary.卵巢黏液性癌中的RAS突变
Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1127-1132. doi: 10.31557/APJCP.2019.20.4.1127.
5
Presurgical diagnostic difficulties in an asymptomatic patient with primary transitional cell carcinoma of the oviduct: case report.一名无症状原发性输卵管移行细胞癌患者的术前诊断困难:病例报告
Prz Menopauzalny. 2018 Jun;17(2):91-93. doi: 10.5114/pm.2018.77309. Epub 2018 Jun 30.
6
Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women?波兰女性附件肿瘤术前鉴别中,卵巢恶性肿瘤算法是否比 HE4 和 CA125 提供更好的诊断性能?
Dis Markers. 2018 Apr 10;2018:5289804. doi: 10.1155/2018/5289804. eCollection 2018.
7
Can Replacing CA125 with HE4 in Risk of Malignancy Indices 1-4 Improve Diagnostic Performance in the Presurgical Assessment of Adnexal Tumors?在术前评估附件肿瘤时,用 HE4 替代 CA125 对风险恶性指数 1-4 是否能改善诊断性能?
Biomed Res Int. 2017;2017:6712376. doi: 10.1155/2017/6712376. Epub 2017 Nov 7.